InMed Engages Peter Mountford as Strategic Advisor

May 5, 2015

Read More »

InMed Pharmaceuticals Qualifies for Electronic Trading in the U.S.

April 30, 2015

Read More »

InMed Awarded Grant for Proprietary Nanoparticle-Based Delivery System for Glaucoma Therapy

April 15, 2015

Read More »

InMed Pharmaceuticals, Inc. Announces Non-Brokered Private Placement for up to C$1,000,000

April 6, 2015

Read More »

InMed Pharmaceuticals Strengthens Scientific Advisory Board

March 31, 2015

Read More »

InMed Receives Exemption Status from Health Canada

March 23, 2015

Read More »

InMed Pharmaceuticals added to CSE Composite Index

March 20, 2015

Read More »

InMed Initiates Pre-clinical Work on Orofacial Pain

March 18, 2015

Read More »

InMed Forms Strategic Collaboration to Develop Novel Phytocannabinoid Therapies for Ocular Allergies

March 10, 2015

Read More »

InMed Pharmaceuticals Appoints Dr. Ado Mohammed as Chief Medical Officer

March 4, 2015

Read More »

InMed Pharmaceuticals to Present Live Investor Webcast March 5, 2015

March 2, 2015

Read More »

InMed Expands Board of Directors with Senior Life Science and Financial Executives Appoints Tarek S. Mansour, Ph.D., and Kevin Puil to Board of Directors

March 2, 2015

Read More »

InMed Pharmaceuticals, Inc. Closes Non-Brokered Private Placement for up to C$1,050,000

February 25, 2015

Read More »

InMed Pharmaceuticals, Inc. Announces Non-Brokered Private Placement for up to C$500,000

February 10, 2015

Read More »

InMed Expands Pipeline with Initiation of Program Targeting Epidermolysis bullosa simplex (EBS)

February 3, 2015

Read More »